Epidemiology

Pioneer Physicians Network Doctors Join Nationwide Physician Campaign Urging Patients to Get COVID-19 Vaccinations

Thursday, February 25, 2021 - 9:43pm

Already, COVID-19 has taken the lives of over 500,000 Americans and over two million worldwide.

Key Points: 
  • Already, COVID-19 has taken the lives of over 500,000 Americans and over two million worldwide.
  • "We were happy to participate in a national video involving physicians from all over the U.S. urging Americans to get the vaccine -- which will ultimately create herd immunity and stop the spread," says Gary Pinta, M.D., President of Pioneer Physicians Network.
  • "Some of our patients are wary about getting vaccinated and we let them know they have nothing to lose and everything to gain."
  • The campaign is a combined effort between agilon health and primary care physicians representing more than 50 independent physician practices across the country.

Doctors Nationwide Band Together to Launch Initiative Urging Patients to Get Vaccinated for COVID-19

Thursday, February 25, 2021 - 9:40pm

Already, COVID-19 has taken the lives of 500,000 Americans and over two million people worldwide.

Key Points: 
  • Already, COVID-19 has taken the lives of 500,000 Americans and over two million people worldwide.
  • "While we encourage all patients to get vaccinated, we feel compelled to do something on a larger scale to urge patients to create herd immunity, which ultimately will stop the infection and help save lives."
  • 'Herd immunity,' or 'population immunity,' happens when a population is immune either through vaccination or immunity developed through the previous infection.
  • According to research released by the Kaiser Family Foundation , 35 percent of black Americans have expressed hesitancy towards getting vaccinated.

Chembio Diagnostics to Report Fourth Quarter and Full Year 2020 Financial Results on March 11, 2021

Thursday, February 25, 2021 - 9:05pm

HAUPPAUGE, N.Y., Feb. 25, 2021 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, announced today that it will release financial results for the fourth quarter and full year 2020 after the close of trading on Thursday, March 11, 2021.

Key Points: 
  • HAUPPAUGE, N.Y., Feb. 25, 2021 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, announced today that it will release financial results for the fourth quarter and full year 2020 after the close of trading on Thursday, March 11, 2021.
  • The companys management team will host a corresponding conference call beginning at 4:30 p.m. Eastern Time.
  • Chembio is a leading point-of-care diagnostics company focused on detecting and diagnosing infectious diseases, including COVID-19, sexually transmitted disease, and fever and tropical disease.
  • Coupled with Chembios extensive scientific expertise, its novel DPP technology offers broad market applications beyond infectious disease.

5th Annual Infection Control, Sterilization & Decontamination Conference: Two Day Online Conference - March 25th-26th, 2021 - ResearchAndMarkets.com

Thursday, February 25, 2021 - 1:22pm

The "5th Annual Infection Control, Sterilization & Decontamination Virtual Conference (GMT)" conference has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "5th Annual Infection Control, Sterilization & Decontamination Virtual Conference (GMT)" conference has been added to ResearchAndMarkets.com's offering.
  • Based on the survey on 1,000 hospitals in 33 countries, European Centre for Disease Prevention and Control (ECDC) estimates that that on any given day, one in 18 patients in a European hospital has a healthcare-associated infection (HAIs).
  • Most of the countries (26 out of 33) reported the major three types of HAIs: pneumonia and lower respiratory tract infection, surgical site infection, and urinary tract infection.
  • The 5th Annual Infection Control, Sterilization, and Decontamination in Healthcare Virtual Conference, scheduled for 25th & 26th March 2021, aiming at providing platform to experts from hospitals, academia, and government institutions discussing the innovations, challenges, and future aspects of infection control, decontamination, and sterilization.

Global Heavy Metal Poisoning Epidemiology Forecast Report 2017-2020 & 2021-2030 - ResearchAndMarkets.com

Tuesday, February 23, 2021 - 4:28pm

The Heavy Metal Poisoning epidemiology report gives a thorough understanding of the heavy metal poisoning by including details such as disease definition, symptoms, causes, pathophysiology, and diagnosis.

Key Points: 
  • The Heavy Metal Poisoning epidemiology report gives a thorough understanding of the heavy metal poisoning by including details such as disease definition, symptoms, causes, pathophysiology, and diagnosis.
  • The heavy metal poisoning report and model provide an overview of the global trends of heavy metal poisoning in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan).
  • The heavy metal poisoning epidemiology report will allow the user to:
    Develop business strategies by understanding the trends shaping and driving the heavy metal poisoning market.
  • Quantify patient populations in the global heavy metal poisoning market to improve product design, pricing, and launch plans
    The Heavy Metal Poisoning Epidemiology Model developed by the publisher is easy to navigate, interactive with dashboards, and epidemiology based with transparent and consistent methodologies.

RURAL Cohort Study to Utilize PixCell Medical's HemoScreen™ Hematology Analyzer for Research Initiative

Tuesday, February 23, 2021 - 1:00pm

Focusing on ten rural counties in Alabama, Kentucky, Louisiana, and Mississippi, the research team will examine about 4,600 residents to study different aspects of their health.

Key Points: 
  • Focusing on ten rural counties in Alabama, Kentucky, Louisiana, and Mississippi, the research team will examine about 4,600 residents to study different aspects of their health.
  • The HemoScreen will be a key piece of research equipment in our cohort study."
  • RURAL plans to deploy HemoScreen hematology analyzers within the MEU lab to do phenotypic measurements in a non-clinical research setting in the rural south, and to test the performance characteristics of the HemoScreen in this setting.
  • For those living in rural areas with limited access to lab-grade diagnostic devices, HemoScreen can play an important role in gathering hematological data to support the research efforts of the RURAL cohort study," said Dr. Avishay Bransky, CEO of PixCell Medical.

Global Dried Blood Spot Collection Cards Market (2020 to 2027) - Share, Size, Trends, Industry Analysis Report

Monday, February 22, 2021 - 5:15pm

The global dried blood spot collection cards market expected to reach USD 339.5 million by 2027, according to the study.

Key Points: 
  • The global dried blood spot collection cards market expected to reach USD 339.5 million by 2027, according to the study.
  • The recent surge in COVID-19 pandemic, rising newborn screening through dried blood spot collection cards for hereditary and metabolic disorders, innovations, and its wide applicability in diagnosing varied diseases coupled with new product launches are few factors attributed to the market growth for dried blood spot collection cards.
  • The global dried blood spot collection cards industry is fragmented based on card type, application, and region.
  • Qiagen, PerkinElmer, and Roche Diagnostics are a few of the major market players operating in the dried blood spot collection cards industry.

Biohaven's BHV-1200, A Multimodal Antibody Therapy Enhancer (MATE), Demonstrates Effective Neutralization Of Multiple Strains Of COVID-19

Monday, February 22, 2021 - 12:30pm

The preliminary experiments, conducted by Biohaven Labs and an academic collaborator demonstrated that BHV-1200 substantially reduced viral entry into cells.

Key Points: 
  • The preliminary experiments, conducted by Biohaven Labs and an academic collaborator demonstrated that BHV-1200 substantially reduced viral entry into cells.
  • Vlad Coric M.D., Chief Executive Officer of Biohaven commented, "The battle against COVID-19 like the virus itselfis dynamic and ever changing.
  • Prophylactic and therapeutic agents with broad specificity against current and future strains will be essential in this ongoing fight to beat the virus.
  • Dr. Coric added, "We believe that BHV-1200 could lead to enhanced efficacy and other benefits over convalescent plasma and alternative antibody-based approaches.

COVID-19 Technology Task Force Launches "Connect and Protect" PSA Campaign to Help States and Public Health Authorities Promote Adoption of Phone-Based Exposure Notifications

Friday, February 19, 2021 - 1:00pm

This year began with a dramatic increase in cases, placing additional pressure on state leaders and public health authorities around the country using traditional methods ofcontact tracing to help control the spread.

Key Points: 
  • This year began with a dramatic increase in cases, placing additional pressure on state leaders and public health authorities around the country using traditional methods ofcontact tracing to help control the spread.
  • A key focus of the campaign is communities of color, which have been disproportionallyimpacted by the virus.
  • "Phone-based Exposure Notifications can be a powerful public health tool to help control the spread of COVID-19 and save thousands of lives," said Dr. Rajiv J. Shah, President, The Rockefeller Foundation.
  • We can all do our part to protectour friends, loved ones and communities by enabling our phones to receive Exposure Notifications."

Pacific Biosciences Sequel II Systems Deployed to Scale-Up Global Viral Surveillance Initiatives Focused on COVID-19

Thursday, February 18, 2021 - 1:01pm

The new systems will expand Labcorps capacity to generate thousands of more complete coronavirus genomes from patient samples each week.

Key Points: 
  • The new systems will expand Labcorps capacity to generate thousands of more complete coronavirus genomes from patient samples each week.
  • The emergence of more infectious mutations in the United States, United Kingdom, South Africa and elsewhere has reinforced the urgent need for expansive and robust viral surveillance strategies.
  • Governments and public health organizations around the world are moving quickly to identify and track the different COVID strains in their communities using complete viral genome sequencing.
  • PacBio is pleased to be collaborating with Labcorp to help advance these critical public health efforts, said Christian Henry, President and Chief Executive Officer of Pacific Biosciences.